North America Hip Replacement Devices Market

North America Hip Replacement Devices Market Size (2023 to 2028)

The size of the Hip replacement devices Market in North America was worth USD 1.94 billion in 2023 and estimated to be growing at a CAGR of 3.3%, to reach USD 2.28 billion by 2028.

Increased demand for hip replacement surgical operations, an aging population, and a high frequency of lower extremity disorders such as osteoarthritis (OA), osteoporosis, and hip problems are expected to drive the hip replacement devices market forward in the North American region. The prevalence of low healthcare facilities in this country and technical advancements in non-invasive surgeries are projected to propel the market forward. Non-metal materials like polymer and ceramic are intended to alleviate issues with traditional devices such as increased metallic ions in patients' bloodstreams and implant deterioration over time. Over the forecast period, the rising number of younger people suffering from degenerative diseases is expected to impact income positively.

Furthermore, a boost in the number of robot-assisted operations has increased the success rate of minimally invasive surgeries, which is expected to generate profitable growth opportunities for this market in the near future. Osteoarthritis has become more common in recent years. The key driving force behind this industry is the rising prevalence of osteoarthritis. Furthermore, the North American market is expected to be driven by an increased patient population, a rise in demand for personalized hip implants, and a surge in government initiatives.

Strict FDA rules for all-metal hip implant products, high surgical costs, and a lack of awareness in rural parts of various emerging economies are just a few of the factors limiting the growth of the hip reconstruction device market. Furthermore, the market's growth is also being hampered by problems such as a scarcity of competent medical professionals and doctors and a lack of norms and protocols. Additionally, during the forecast period, increased awareness of alternative treatments is expected to slow growth. Furthermore, pricing pressure, hip dislocation, the danger of complications following surgery, and the time it takes for surgery in hospitals are all possible restrictions on the hip replacement devices market's overall growth.

This research report on the North American hip replacement devices market has been segmented and sub-segmented into the following categories:

By product:

• Total Procedure
• Fixed
• Mobile-Bearing
• Partial Hip Replacement
• Hip Resurfacing
• Revision Hip Replacement

By Material:

• Metal
• Metal on Polyethylene
• Ceramic on Metal
• Ceramic on Polyethylene
• Ceramic on Ceramic

By End-user:

• Ambulatory Surgical Centres
• Hospitals
• Orthopedic Clinics

By Country:

• The United States
• Canada
• Rest of North America

Geographically, due to its favorable healthcare infrastructure and the presence of significant industry players, North America had the biggest share in the global market in 2022. The rising number of sports and road injuries is contributing to the regional market's rise. In addition, patient-friendly reimbursement policies are expected to enhance the market in this region by increasing the number of procedures performed. Other factors, such as an increase in the number of injuries and an increase in the obese population, also contribute to the market's growth. The expansion of the hip replacement devices market in the United States is more. It is expected to be aided by an increase in specialist care centers, a growing population. Total hip and knee arthroplasties are among the most effective joint reconstruction surgeries available today. In the next ten years, demand for these treatments is predicted to rise, owing to the aging of the baby boomer population and the obesity pandemic in the United States.

KEY MARKET PLAYERS:

Companies playing a vital role in the North American hip replacement market profiled in this report are B. Braun Melsungen AG, Exactech, Inc., DJO Global, Inc., Johnson & Johnson, MicroPort Scientific Corporation, OMNIlife science, Inc., Smith & Nephew, Zimmer Biomet Holdings, Inc., and Stryker Corporation.